Gene · 4751
Papers2,227
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,227
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications. | Cancers (Basel) | 2023 | 37444544 | PubTator, text mining | PubMed |
| Bioinformatics analysis to identify breast cancer-related potential targets and candidate small molecule drugs. | Mutat Res | 2023 | 37437506 | PubTator, text mining | PubMed |
| Screening of novel biomarkers for breast cancer based on WGCNA and multiple machine learning algorithms. | Transl Cancer Res | 2023 | 37434679 | PubTator, text mining | PubMed |
| Identifying hub genes and common biological pathways between COVID-19 and benign prostatic hyperplasia by machine learning algorithms. | Front Immunol | 2023 | 37426635 | PubTator, text mining | PubMed |
| Identification of Immune Subtypes and Candidate mRNA Vaccine Antigens in Small Cell Lung Cancer. | Oncologist | 2023 | 37399175 | PubTator, text mining | PubMed |
| A novel camptothecin derivative, ZBH-01, exhibits superior antitumor efficacy than irinotecan by regulating the cell cycle. | J Transl Med | 2023 | 37386467 | PubTator, text mining | PubMed |
| UBE2C expression is elevated in hepatoblastoma and correlates with inferior patient survival. | Front Genet | 2023 | 37377594 | PubTator, text mining | PubMed |
| The Recent Research Progress of NF-κB Signaling on the Proliferation, Migration, Invasion, Immune Escape and Drug Resistance of Glioblastoma. | Int J Mol Sci | 2023 | 37373484 | PubTator, text mining | PubMed |
| Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer. | Breast Cancer Res | 2023 | 37370117 | PubTator, text mining | PubMed |
| Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma. | Front Oncol | 2023 | 37361580 | PubTator, text mining | PubMed |
| Circular RNAs in gynecologic cancers: mechanisms and implications for chemotherapy resistance. | Front Pharmacol | 2023 | 37361215 | PubTator, text mining | PubMed |
| NEK2 overexpression aggravates IL-22-induced keratinocyte proliferation and cytokine level increases and IMQ-induced psoriasis-like dermatitis. | Biochim Biophys Acta Mol Cell Res | 2023 | 37348763 | PubTator, text mining | PubMed |
| Applications of palladium-catalyzed C-N cross-coupling reactions in pharmaceutical compounds. | RSC Adv | 2023 | 37346956 | PubTator, text mining | PubMed |
| Identification of a polycomb group-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma. | J Thorac Dis | 2023 | 37324109 | PubTator, text mining | PubMed |
| Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer. | Ann Oncol | 2023 | 37302750 | PubTator, text mining | PubMed |
| Leucyl and Cystinyl Aminopeptidase as a Prognostic-Related Biomarker in OV Correlating with Immune Infiltrates. | Pharmgenomics Pers Med | 2023 | 37293607 | PubTator, text mining | PubMed |
| The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma. | Front Pharmacol | 2023 | 37292151 | PubTator, text mining | PubMed |
| The GCN2/eIF2αK stress kinase regulates PP1 to ensure mitotic fidelity. | EMBO Rep | 2023 | 37291955 | PubTator, text mining | PubMed |
| Regulation of PD-L1 Trafficking from Synthesis to Degradation. | Cancer Immunol Res | 2023 | 37290119 | PubTator, text mining | PubMed |
| BrcaDx: precise identification of breast cancer from expression data using a minimal set of features. | Front Bioinform | 2023 | 37287543 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4751/papers?page=12